Skip to main content

Table 1 Baseline characteristics and clinical presentation of 201 children for the CHD and non-CHD cohort

From: Effect of congenital heart disease on the recurrence of cough variant asthma in children

Characteristic

Non-CHD

CHD

P value

N = 134

N = 67

N

%

N

%

Clinical presentation

Age (year)

    

0.99

 1–3

54

40.3

27

40.3

 

 4–6

38

28.4

19

28.4

 

 7–14

42

31.3

21

31.3

 

Sex

    

0.99

 Male

74

55.2

37

55.2

 

 Female

60

44.8

30

44.8

 

Family history of allergies

123

91.8

57

85.1

0.150

Family history of eczema

64

47.8

30

44.8

0.689

Family history of asthma

26

19.4

14

20.9

0.803

Laboratory examination

     

Elevated eosinophil ratio

44

32.8

18

26.8

0.388

Mycoplasma pneumonia positive

69

51.5

38

56.7

0.484

sIgE sensitization

85

63.4

40

59.7

0.607

Food

70

52.2

32

47.8

0.549

Aeroallergen

84

62.7

37

55.2

0.308

Treatment

    

0.99

Fluticasone Propionate inhalation aerosol (flixotide) + salbutamol

92

68.7

46

68.7

 

Salmeterol xinafoate and fluticasone propionate powder for inhalation (seretide) + salbutamol

42

31.3

21

31.3

 
  1. CHD congenital heart disease